Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 6.41x is 27% below its estimated 5-year average of 8.75x, near the low end of its estimated 5-year range (2.63x–341.37x).
As of 2026-10-06T14:16:58.616Z. 8.64% above its estimated 12-month average of 5.90x.
Calculation as of: 2026-10-06T14:16:58.616Z.
Quote observation: 2026-10-06T14:15:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0c00d818a788336e8bc85b69affa9d7057207beb35ad975aac8b5a949e44e0f4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
6.41x
EV/SALES RATIO AVG TTM
5.90x
EV/SALES RATIO AVG 3Y
8.85x
EV/SALES RATIO AVG 5Y
8.75x
EV/SALES RATIO AVG 10Y
97.20x
EV/SALES RATIO AVG 15Y
147.22x
EV/SALES RATIO AVG 20Y
134.58x
CURRENT VS TTM AVG
+8.64%
CURRENT VS 3Y AVG
-27.53%
CURRENT VS 5Y AVG
-26.73%
CURRENT VS 10Y AVG
-93.41%
CURRENT VS 15Y AVG
-95.65%
CURRENT VS 20Y AVG
-95.24%
SECTOR MEDIAN · HEALTHCARE
4.18x
median of 375 covered companies
CURRENT VS SECTOR MEDIAN
+53.35%
vs the sector median at left
Gyre Therapeutics, Inc.
Market Cap
$804.95M
EV/Sales Ratio
6.41x
TTM Avg
5.90x
3Y Avg
8.85x
5Y Avg
8.75x
Market Cap
$826.99M
EV/Sales Ratio
108.10x
TTM Avg
171.82x
3Y Avg
125.82x
5Y Avg
125.82x
Market Cap
$777.46M
EV/Sales Ratio
3.40x
TTM Avg
2.72x
3Y Avg
3.17x
5Y Avg
4.51x
Market Cap
$770.68M
EV/Sales Ratio
19.03x
TTM Avg
12.42x
3Y Avg
202.88x
5Y Avg
983.65x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | $804.95M | 6.41x | 5.90x | 8.85x | 8.75x |
| InMode Ltd. (INMD)vs › | $809.46M | 1.12x | 1.58x | 2.61x | 5.65x |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | 2.15x | 3.70x | 6.27x | 11.43x |
| AdaptHealth Corp. (AHCO)vs › | $797.93M | 0.94x | 1.16x | 1.13x | 1.47x |
| Jade Biosciences, Inc. (JBIO)vs › | $811.26M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $817.57M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $826.99M | 108.10x | 171.82x | 125.82x | 125.82x |
| Mesa Laboratories, Inc. (MLAB)vs › | $777.46M | 3.40x | 2.72x | 3.17x | 4.51x |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $770.68M | 19.03x | 12.42x | 202.88x | 983.65x |
| Geron Corporation (GERN)vs › | $766.87M | 4.04x | 5.53x | 1615.59x | 1480.74x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 5.86x |
| 2026-10-02 | 5.66x |
| 2026-10-01 | 5.57x |
| 2026-09-30 | 5.85x |
| 2026-09-29 | 5.84x |
| 2026-09-28 | 5.98x |
| 2026-09-25 | 5.86x |
| 2026-09-24 | 5.85x |
| 2026-09-23 | 5.90x |
| 2026-09-22 | 5.98x |
| 2026-09-21 | 5.93x |
| 2026-09-18 | 6.03x |
| 2026-09-17 | 5.72x |
| 2026-09-16 | 5.31x |
| 2026-09-15 | 5.31x |
| 2026-09-14 | 5.31x |
| 2026-09-11 | 5.34x |
| 2026-09-10 | 5.35x |
| 2026-09-09 | 5.52x |
| 2026-09-08 | 5.71x |
| 2026-09-04 | 5.45x |
| 2026-09-03 | 5.09x |
| 2026-09-02 | 5.03x |
| 2026-09-01 | 5.12x |
| 2026-08-31 | 5.20x |
| 2026-08-28 | 5.22x |
| 2026-08-27 | 5.30x |
| 2026-08-26 | 5.27x |
| 2026-08-25 | 5.30x |
| 2026-08-24 | 5.09x |
| 2026-08-21 | 5.49x |
| 2026-08-20 | 5.58x |
| 2026-08-19 | 5.69x |
| 2026-08-18 | 5.55x |
| 2026-08-17 | 5.41x |
| 2026-08-14 | 5.30x |
| 2026-08-13 | 5.18x |
| 2026-08-12 | 5.28x |
| 2026-08-11 | 5.26x |
| 2026-08-10 | 5.33x |
| 2026-08-07 | 4.77x |
| 2026-08-06 | 4.57x |
| 2026-08-05 | 4.44x |
| 2026-08-04 | 4.38x |
| 2026-08-03 | 4.34x |
| 2026-07-31 | 4.07x |
| 2026-07-30 | 4.12x |
| 2026-07-29 | 3.99x |
| 2026-07-28 | 4.25x |
| 2026-07-27 | 4.36x |
| 2026-07-24 | 4.22x |
| 2026-07-23 | 4.27x |
| 2026-07-22 | 4.22x |
| 2026-07-21 | 4.31x |
| 2026-07-20 | 4.17x |
| 2026-07-17 | 4.30x |
| 2026-07-16 | 4.58x |
| 2026-07-15 | 4.69x |
| 2026-07-14 | 4.52x |
| 2026-07-13 | 4.52x |
| 2026-07-10 | 4.66x |
| 2026-07-09 | 4.92x |
| 2026-07-08 | 4.92x |
| 2026-07-07 | 5.03x |
| 2026-07-06 | 5.22x |
| 2026-07-02 | 5.28x |
| 2026-07-01 | 4.66x |
| 2026-06-30 | 4.71x |
| 2026-06-29 | 4.60x |
| 2026-06-26 | 4.48x |
| 2026-06-25 | 4.44x |
| 2026-06-24 | 4.63x |
| 2026-06-23 | 4.36x |
| 2026-06-22 | 4.36x |
| 2026-06-18 | 4.45x |
| 2026-06-17 | 4.32x |
| 2026-06-16 | 4.12x |
| 2026-06-15 | 4.15x |
| 2026-06-12 | 4.21x |
| 2026-06-11 | 4.31x |
| 2026-06-10 | 4.22x |
| 2026-06-09 | 4.36x |
| 2026-06-08 | 4.30x |
| 2026-06-05 | 4.48x |
| 2026-06-04 | 4.41x |
| 2026-06-03 | 4.03x |
| 2026-06-02 | 3.93x |
| 2026-06-01 | 4.12x |
| 2026-05-29 | 4.19x |
| 2026-05-28 | 4.06x |
| 2026-05-27 | 4.20x |
| 2026-05-26 | 4.22x |
| 2026-05-22 | 4.31x |
| 2026-05-21 | 4.40x |
| 2026-05-20 | 4.29x |
| 2026-05-19 | 4.46x |
| 2026-05-18 | 4.60x |
| 2026-05-15 | 4.68x |
| 2026-05-14 | 5.02x |
| 2026-05-13 | 5.24x |
| 2026-05-12 | 5.25x |
| 2026-05-11 | 5.09x |
| 2026-05-08 | 6.13x |
| 2026-05-07 | 5.79x |
| 2026-05-06 | 6.62x |
| 2026-05-05 | 6.40x |
| 2026-05-04 | 6.52x |
| 2026-05-01 | 6.41x |
| 2026-04-30 | 6.31x |
| 2026-04-29 | 6.03x |
| 2026-04-28 | 6.30x |
| 2026-04-27 | 6.27x |
| 2026-04-24 | 6.10x |
| 2026-04-23 | 6.10x |
| 2026-04-22 | 6.35x |
| 2026-04-21 | 6.47x |
| 2026-04-20 | 6.53x |
| 2026-04-17 | 6.67x |
| 2026-04-16 | 6.50x |
| 2026-04-15 | 6.60x |
| 2026-04-14 | 6.45x |
| 2026-04-13 | 6.32x |
| 2026-04-10 | 6.06x |
| 2026-04-09 | 5.93x |
| 2026-04-08 | 5.80x |
| 2026-04-07 | 5.83x |
| 2026-04-06 | 5.83x |
| 2026-04-02 | 5.83x |
| 2026-04-01 | 5.92x |
| 2026-03-31 | 5.70x |
| 2026-03-30 | 5.59x |
| 2026-03-27 | 5.54x |
| 2026-03-26 | 5.76x |
| 2026-03-25 | 5.88x |
| 2026-03-24 | 5.67x |
| 2026-03-23 | 5.76x |
| 2026-03-20 | 5.48x |
| 2026-03-19 | 5.55x |
| 2026-03-18 | 5.73x |
| 2026-03-17 | 6.28x |
| 2026-03-16 | 6.16x |
| 2026-03-13 | 6.69x |
| 2026-03-12 | 6.92x |
| 2026-03-11 | 7.41x |
| 2026-03-10 | 7.21x |
| 2026-03-09 | 7.25x |
| 2026-03-06 | 6.83x |
| 2026-03-05 | 6.94x |
| 2026-03-04 | 7.36x |
| 2026-03-03 | 7.00x |
| 2026-03-02 | 7.81x |
| 2026-02-27 | 7.32x |
| 2026-02-26 | 7.58x |
| 2026-02-25 | 7.70x |
| 2026-02-24 | 7.47x |
| 2026-02-23 | 7.24x |
| 2026-02-20 | 7.36x |
| 2026-02-19 | 7.49x |
| 2026-02-18 | 7.29x |
| 2026-02-17 | 7.29x |
| 2026-02-13 | 7.12x |
| 2026-02-12 | 6.93x |
| 2026-02-11 | 6.96x |
| 2026-02-10 | 7.07x |
| 2026-02-09 | 6.93x |
| 2026-02-06 | 6.99x |
| 2026-02-05 | 6.64x |
| 2026-02-04 | 6.88x |
| 2026-02-03 | 7.02x |
| 2026-02-02 | 7.29x |
| 2026-01-30 | 7.18x |
| 2026-01-29 | 7.29x |
| 2026-01-28 | 7.13x |
| 2026-01-27 | 7.18x |
| 2026-01-26 | 7.00x |
| 2026-01-23 | 6.96x |
| 2026-01-22 | 7.14x |
| 2026-01-21 | 7.38x |
| 2026-01-20 | 7.03x |
| 2026-01-16 | 6.80x |
| 2026-01-15 | 6.82x |
| 2026-01-14 | 6.81x |
| 2026-01-13 | 6.90x |
| 2026-01-12 | 6.82x |
| 2026-01-09 | 6.54x |
| 2026-01-08 | 6.70x |
| 2026-01-07 | 6.45x |
| 2026-01-06 | 6.14x |
| 2026-01-05 | 7.02x |
| 2026-01-02 | 5.99x |
| 2025-12-31 | 6.22x |
| 2025-12-30 | 6.18x |
| 2025-12-29 | 6.32x |
| 2025-12-26 | 6.41x |
| 2025-12-24 | 6.34x |
| 2025-12-23 | 6.33x |
| 2025-12-22 | 6.34x |
| 2025-12-19 | 6.29x |
| 2025-12-18 | 6.49x |
| 2025-12-17 | 6.55x |
| 2025-12-16 | 6.71x |
| 2025-12-15 | 6.67x |
| 2025-12-12 | 6.81x |
| 2025-12-11 | 6.98x |
| 2025-12-10 | 7.53x |
| 2025-12-09 | 7.14x |
| 2025-12-08 | 7.25x |
| 2025-12-05 | 7.08x |
| 2025-12-04 | 7.00x |
| 2025-12-03 | 6.76x |
| 2025-12-02 | 6.71x |
| 2025-12-01 | 6.79x |
| 2025-11-28 | 6.86x |
| 2025-11-26 | 6.96x |
| 2025-11-25 | 6.84x |
| 2025-11-24 | 6.98x |
| 2025-11-21 | 6.68x |
| 2025-11-20 | 6.62x |
| 2025-11-19 | 6.70x |
| 2025-11-18 | 6.79x |
| 2025-11-17 | 7.12x |
| 2025-11-14 | 7.09x |
| 2025-11-13 | 7.17x |
| 2025-11-12 | 7.41x |
| 2025-11-11 | 7.11x |
| 2025-11-10 | 7.02x |
| 2025-11-07 | 5.78x |
| 2025-11-06 | 5.89x |
| 2025-11-05 | 5.94x |
| 2025-11-04 | 5.82x |
| 2025-11-03 | 5.91x |
| 2025-10-31 | 6.24x |
| 2025-10-30 | 6.16x |
| 2025-10-29 | 6.06x |
| 2025-10-28 | 6.23x |
| 2025-10-27 | 6.47x |
| 2025-10-24 | 6.60x |
| 2025-10-23 | 6.65x |
| 2025-10-22 | 6.36x |
| 2025-10-21 | 6.72x |
| 2025-10-20 | 6.74x |
| 2025-10-17 | 6.71x |
| 2025-10-16 | 7.08x |
| 2025-10-15 | 7.19x |
| 2025-10-14 | 6.46x |
| 2025-10-13 | 6.78x |
| 2025-10-10 | 6.42x |
| 2025-10-09 | 5.73x |
| 2025-10-08 | 5.86x |
| 2025-10-07 | 5.83x |
| 2025-10-06 | 5.89x |
| 2025-10-03 | 5.95x |
| 2025-10-02 | 6.05x |
| 2025-10-01 | 6.10x |
| 2025-09-30 | 5.99x |
| 2025-09-29 | 6.03x |
| 2025-09-26 | 5.74x |
| 2025-09-25 | 5.85x |
| 2025-09-24 | 5.92x |
| 2025-09-23 | 5.86x |
Showing the most recent 260 of 4,355 data points. The chart above shows the full history.
